INS and diabetes mellitus: In case of diabetes and diabetes-associated dysfunctions, effective delivery of insulin via oral route by these nanoformulations is highly preferred compared to the available parenteral preparations, due to a higher patient compliance (Wilczewska et al., 2012; Fangueiro et al., 2015; Maity et al., 2017).